LI
ABBV icon

LRI Investments’s AbbVie ABBV Stock Holding History

LRI Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84M Sell
11,289
-589
-5% -$127K 0.23% 56
2026
Q1 		$2.58M Sell
11,878
-2,957
-20% -$656K 0.23% 52
2025
Q4 		$3.39M Sell
14,835
-480
-3% -$109K 0.27% 41
2025
Q3 		$3.55M Buy
15,315
+248
+2% +$50.5K 0.29% 40
2025
Q2 		$2.8M Buy
15,067
+148
+1% +$27.5K 0.24% 43
2025
Q1 		$3.13M Sell
14,919
-43
-0.3% -$8.36K 0.3% 38
2024
Q4 		$2.66M Buy
14,962
+987
+7% +$181K 0.26% 34
2024
Q3 		$2.37M Buy
13,975
+4,723
+51% +$881K 0.23% 38
2024
Q2 		$1.59M Buy
9,252
+4,042
+78% +$670K 0.18% 45
2024
Q1 		$949K Buy
+5,210
New +$898K 0.24% 49

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LRI Investments's ABBV Position: Q2 2026 in Review

LRI Investments reduced its AbbVie (ABBV) stake by 5% in Q2 2026, selling an estimated $127K and leaving 11,289 shares worth $2.84M. The position accounts for 0.23% of the portfolio, ranked #56.

LRI Investments first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.55M in Q3 2025. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LRI Investments held 11,289 shares of AbbVie worth $2.84M as of Q2 2026.
  • LRI Investments sold 589 AbbVie shares in Q2 2026, an estimated $127K.
  • AbbVie made up 0.23% of LRI Investments's portfolio in Q2 2026, its #56 holding.
  • LRI Investments first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's AbbVie position peaked at $3.55M in Q3 2025.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.